Clinical trial reportThe New England journal of medicinePublished
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia
Regional connection
Verified An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source
- Institution
- Children’s Hospital of Philadelphia
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- The New England journal of medicine
- Published
- Topic
- Clinical care
- Subject terms
- Neutrophils; Humans; beta-Thalassemia; Busulfan; Fetal Hemoglobin; Repressor Proteins; Myeloablative Agonists; Treatment Outcome; Erythrocyte Transfusion; Transplantation Conditioning; Hematopoietic Stem Cell Transplantation; Adolescent
- PubMed ID
- 41931048
- Added to directory
- Source checked